The PEERLESS II Study
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bernhard Gebauer, MD
Charité University Hospital Berlin
Principal Investigator - Felix Mahfoud, MD
Universitaetsspital Basel
Principal Investigator - Frances Mae West, MD
Jefferson Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
77 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Onze Lieve Vrouwziekenhuis
Aalst, Belgium
- Royal Columbian Hospital
New Westminster, British Columbia, Canada
- Surrey Memorial Hospital
Surrey, British Columbia, Canada
- Vancouver General Hospital
Vancouver, British Columbia, Canada
- Aarhus University Hospital
Aarhus, Denmark
- Chu Lille
Lille, France
- Hôpital Louis Pradel
Lyon, France
- Ap-Hm Hopital la Timone
Marseille, France
- Hôpital Nord Marseille
Marseille, France
- University Hospital Augsburg
Augsburg, Germany
- Universitäts-Herzzentrum Bad Krozingen
Bad Krozingen, Germany
- Charité Campus Virchow Clinic - Klinik Fuer Radiologie
Berlin, Germany
- Unfall Krankenhaus Berlin
Berlin, Germany
- University Hospital Cologne
Cologne, Germany
- Herzzentrum Dresden Universitaetsklinik
Dresden, Germany
- Universitaetsklinikum Dὒsseldorf
Düsseldorf, Germany
- Elisabeth Hospital Gmbh
Essen, Germany
- Universitaetsklinikum Essen
Essen, Germany
- Ccb Frankfurt
Frankfurt, Germany
- Universitaetsklinikum Hamburg Eppendorf
Hamburg, Germany
- University Hospital - Heidelberg
Heidelberg, Germany
- Westpfalz Klinikum
Kaiserslautern, Germany
- Klinikum Rechts Der Isar (tum)
Munich, Germany
- Ludwig Maximilians-University
Munich, Germany
- University Hospital Regensburg
Regensburg, Germany
- Helios Kliniken Schwerin
Schwerin, Germany
- Schwarzwald-Baar-Klinikum
Villingen-Schwenningen, Germany
- John Paul Ii Hospital
Krakow, Poland
- Hopital Clinico Universitario San Carlos
Madrid, Spain
- Universitaetsspital Basel
Basel, Switzerland
- Universitätsspital Bern
Bern, Switzerland
- Luzerner Kantonsspital
Lucerne, Switzerland
- Brookwood Medical Center
Birmingham, Alabama, United States
- Uab Division of Cardiovascular Disease
Birmingham, Alabama, United States
- Huntington Memorial Hospital
Pasadena, California, United States
- University of Colorado, Denver
Aurora, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- Hca Fl Largo Medical Center
Largo, Florida, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Emory University
Atlanta, Georgia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Nov 2023
- Primary completion
- 31 Aug 2026
- Completion
- 31 Oct 2026
- Last update posted
- 6 Aug 2026
- Registered enrollment
- 1,200
- Registry id
- NCT06055920
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.